Auricular point acupressure to manage aromatase inhibitor-induced arthralgia in postmenopausal breast cancer survivors: A pilot study

Chao Hsing Yeh, Wei Chun Lin, Lorna Kwai Ping Suen, Na Jin Park, Lisa Wood, G. J. Van Londen, Dana Howard Bovbjerg

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose/Objectives: To assess the feasibility of auricular point acupressure to manage aromatase inhibitor-induced arthralgia. Design: Wait list control design. Setting: Outpatient clinics and oncology center. Sample: 20 women with aromatase inhibitor-induced arthralgia. Methods: After baseline data were collected, participants waited one month before they received acupressure once per week for four weeks at a convenient time. The baseline data served as the control comparison. Self-reported measures and blood samples were obtained at baseline, at preintervention, weekly during the intervention, and at postintervention. Main Research Variables: The primary outcomes included pain intensity, pain interference, stiffness, and physical function. Inflammatory cytokines and chemokines were tested. Findings: After the four-week intervention, participants reported decreases in worst pain and pain interference, and improvements in physical function, cancer-related symptom severity, and interference. The proinflammatory cytokines and chemokines displayed a trend of a mean percentage reduction. The anti-inflammatory cytokine interleukin-13 increased from pre-to postintervention. Conclusions: Auricular point acupressure is feasible and may be effective in managing arthralgia in breast cancer survivors. Implications for Nursing: Nurses can administer acupressure in clinical settings, which could enhance the management of aromatase inhibitor-induced arthralgia and contribute to a shift from traditional disease-based biomedical models to a broader, integrative, medical paradigm for managing aromatase inhibitor-induced arthralgia.

Original languageEnglish (US)
Pages (from-to)476-487
Number of pages12
JournalOncology Nursing Forum
Volume44
Issue number4
DOIs
StatePublished - Jul 1 2017
Externally publishedYes

Fingerprint

Acupressure
Aromatase Inhibitors
Arthralgia
Survivors
Breast Neoplasms
Pain
Cytokines
Chemokines
Interleukin-13
Ambulatory Care Facilities
Nursing
Anti-Inflammatory Agents
Nurses
Research
Neoplasms

Keywords

  • Acupressure
  • Aromatase inhibitor-induced arthralgia
  • Breast cancer survivors

ASJC Scopus subject areas

  • Oncology(nursing)

Cite this

Auricular point acupressure to manage aromatase inhibitor-induced arthralgia in postmenopausal breast cancer survivors : A pilot study. / Yeh, Chao Hsing; Lin, Wei Chun; Suen, Lorna Kwai Ping; Park, Na Jin; Wood, Lisa; Van Londen, G. J.; Bovbjerg, Dana Howard.

In: Oncology Nursing Forum, Vol. 44, No. 4, 01.07.2017, p. 476-487.

Research output: Contribution to journalArticle

Yeh, Chao Hsing ; Lin, Wei Chun ; Suen, Lorna Kwai Ping ; Park, Na Jin ; Wood, Lisa ; Van Londen, G. J. ; Bovbjerg, Dana Howard. / Auricular point acupressure to manage aromatase inhibitor-induced arthralgia in postmenopausal breast cancer survivors : A pilot study. In: Oncology Nursing Forum. 2017 ; Vol. 44, No. 4. pp. 476-487.
@article{9f9d7d8f5dbf470e9ce45502fb58ab80,
title = "Auricular point acupressure to manage aromatase inhibitor-induced arthralgia in postmenopausal breast cancer survivors: A pilot study",
abstract = "Purpose/Objectives: To assess the feasibility of auricular point acupressure to manage aromatase inhibitor-induced arthralgia. Design: Wait list control design. Setting: Outpatient clinics and oncology center. Sample: 20 women with aromatase inhibitor-induced arthralgia. Methods: After baseline data were collected, participants waited one month before they received acupressure once per week for four weeks at a convenient time. The baseline data served as the control comparison. Self-reported measures and blood samples were obtained at baseline, at preintervention, weekly during the intervention, and at postintervention. Main Research Variables: The primary outcomes included pain intensity, pain interference, stiffness, and physical function. Inflammatory cytokines and chemokines were tested. Findings: After the four-week intervention, participants reported decreases in worst pain and pain interference, and improvements in physical function, cancer-related symptom severity, and interference. The proinflammatory cytokines and chemokines displayed a trend of a mean percentage reduction. The anti-inflammatory cytokine interleukin-13 increased from pre-to postintervention. Conclusions: Auricular point acupressure is feasible and may be effective in managing arthralgia in breast cancer survivors. Implications for Nursing: Nurses can administer acupressure in clinical settings, which could enhance the management of aromatase inhibitor-induced arthralgia and contribute to a shift from traditional disease-based biomedical models to a broader, integrative, medical paradigm for managing aromatase inhibitor-induced arthralgia.",
keywords = "Acupressure, Aromatase inhibitor-induced arthralgia, Breast cancer survivors",
author = "Yeh, {Chao Hsing} and Lin, {Wei Chun} and Suen, {Lorna Kwai Ping} and Park, {Na Jin} and Lisa Wood and {Van Londen}, {G. J.} and Bovbjerg, {Dana Howard}",
year = "2017",
month = "7",
day = "1",
doi = "10.1188/17.ONF.476-487",
language = "English (US)",
volume = "44",
pages = "476--487",
journal = "Oncology Nursing Forum",
issn = "0190-535X",
publisher = "Oncology Nursing Society",
number = "4",

}

TY - JOUR

T1 - Auricular point acupressure to manage aromatase inhibitor-induced arthralgia in postmenopausal breast cancer survivors

T2 - A pilot study

AU - Yeh, Chao Hsing

AU - Lin, Wei Chun

AU - Suen, Lorna Kwai Ping

AU - Park, Na Jin

AU - Wood, Lisa

AU - Van Londen, G. J.

AU - Bovbjerg, Dana Howard

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Purpose/Objectives: To assess the feasibility of auricular point acupressure to manage aromatase inhibitor-induced arthralgia. Design: Wait list control design. Setting: Outpatient clinics and oncology center. Sample: 20 women with aromatase inhibitor-induced arthralgia. Methods: After baseline data were collected, participants waited one month before they received acupressure once per week for four weeks at a convenient time. The baseline data served as the control comparison. Self-reported measures and blood samples were obtained at baseline, at preintervention, weekly during the intervention, and at postintervention. Main Research Variables: The primary outcomes included pain intensity, pain interference, stiffness, and physical function. Inflammatory cytokines and chemokines were tested. Findings: After the four-week intervention, participants reported decreases in worst pain and pain interference, and improvements in physical function, cancer-related symptom severity, and interference. The proinflammatory cytokines and chemokines displayed a trend of a mean percentage reduction. The anti-inflammatory cytokine interleukin-13 increased from pre-to postintervention. Conclusions: Auricular point acupressure is feasible and may be effective in managing arthralgia in breast cancer survivors. Implications for Nursing: Nurses can administer acupressure in clinical settings, which could enhance the management of aromatase inhibitor-induced arthralgia and contribute to a shift from traditional disease-based biomedical models to a broader, integrative, medical paradigm for managing aromatase inhibitor-induced arthralgia.

AB - Purpose/Objectives: To assess the feasibility of auricular point acupressure to manage aromatase inhibitor-induced arthralgia. Design: Wait list control design. Setting: Outpatient clinics and oncology center. Sample: 20 women with aromatase inhibitor-induced arthralgia. Methods: After baseline data were collected, participants waited one month before they received acupressure once per week for four weeks at a convenient time. The baseline data served as the control comparison. Self-reported measures and blood samples were obtained at baseline, at preintervention, weekly during the intervention, and at postintervention. Main Research Variables: The primary outcomes included pain intensity, pain interference, stiffness, and physical function. Inflammatory cytokines and chemokines were tested. Findings: After the four-week intervention, participants reported decreases in worst pain and pain interference, and improvements in physical function, cancer-related symptom severity, and interference. The proinflammatory cytokines and chemokines displayed a trend of a mean percentage reduction. The anti-inflammatory cytokine interleukin-13 increased from pre-to postintervention. Conclusions: Auricular point acupressure is feasible and may be effective in managing arthralgia in breast cancer survivors. Implications for Nursing: Nurses can administer acupressure in clinical settings, which could enhance the management of aromatase inhibitor-induced arthralgia and contribute to a shift from traditional disease-based biomedical models to a broader, integrative, medical paradigm for managing aromatase inhibitor-induced arthralgia.

KW - Acupressure

KW - Aromatase inhibitor-induced arthralgia

KW - Breast cancer survivors

UR - http://www.scopus.com/inward/record.url?scp=85020553056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020553056&partnerID=8YFLogxK

U2 - 10.1188/17.ONF.476-487

DO - 10.1188/17.ONF.476-487

M3 - Article

C2 - 28632237

AN - SCOPUS:85020553056

VL - 44

SP - 476

EP - 487

JO - Oncology Nursing Forum

JF - Oncology Nursing Forum

SN - 0190-535X

IS - 4

ER -